AstraZeneca

The U.S. Antidepressant Market: Old Fashioned Branding Might Save the Day
Motley Fool
Fri, 07/19/13 - 10:31 am
antidepressants
AstraZeneca
Eli Lilly
Forest Labs
GSK
Pfizer
Targacept
Cymbalta
Lexapro
Effexor
Pristiq
TC-5214
Expect Huge Upside to This Biotech Stock as It Approaches FDA Approval
Motley Fool
Mon, 07/15/13 - 10:27 am
FDA
AstraZeneca
Novartis
Acadia
pimavanserin
After $240 Million AstraZeneca Deal, How Big Will Moderna Get?
Forbes
Fri, 07/12/13 - 10:07 am
Moderna
AstraZeneca
MRNA
Common Acid Reflux Drugs May Lead To Heart Disease, New Research Suggests
Forbes
Fri, 07/12/13 - 08:41 am
acid reflux
proton pump inhibitors
Nexium
Prevacid
GERD
Prilosec
AstraZeneca
Takeda
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thu, 07/11/13 - 11:15 am
Astex
AstraZeneca
Celgene
GSK
JNJ
Novartis
SGI-110
Dacogen
Why AstraZeneca plc's Patent Cliff Presents A Golden Opportunity
Motley Fool
Wed, 07/3/13 - 11:26 am
patent cliff
AstraZeneca
Merck: Implications Of Capital Allocation
Seeking Alpha
Wed, 07/3/13 - 11:07 am
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Merck
capital allocation
Vivus's top shareholder proposes former AstraZeneca exec as CEO
Reuters
Tue, 07/2/13 - 09:45 am
Vivus
AstraZeneca
Anthony Zook
Bristol-Myers Squibb: Valuation Dependent On Pipeline
Seeking Alpha
Mon, 07/1/13 - 12:31 pm
Bristol-Myers Squibb
AstraZeneca
Generic Versions of AstraZeneca’s Pulmicort Respules Enjoined from Launch Pending Appeal in Patent Infringement Case
National Law Review
Sun, 06/30/13 - 11:06 am
AstraZeneca
Pulmicort
generics
Patent Infringement
lawsuits
Fish-Oil Pills Lure Drugmakers Even as Benefits Unproven
Bloomberg
Fri, 06/28/13 - 10:23 am
Amarin
fish oil
AstraZeneca
GSK
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza
New AMA Obesity Ruling Should Push Big Pharma To Find Acquisitions
Seeking Alpha
Thu, 06/27/13 - 09:59 am
obesity
M&A
Oramed
AstraZeneca
MannKind
Merck
Sanofi
Novo Nordisk
Roche and AstraZeneca launch medicinal chemistry data-sharing consortium to further accelerate drug discovery
Fierce Biotech
Wed, 06/26/13 - 10:51 am
clinical trials
Roche
AstraZeneca
Troubled AstraZeneca models a new industry R&D tie-up as setbacks mount
Fierce Biotech
Mon, 06/24/13 - 11:12 am
AstraZeneca
Pascal Soriot
R&D
Amgen
Bristol-Myers Squibb
New GSK diabetes drug works, but faces tough competition
Reuters
Mon, 06/24/13 - 10:28 am
GSK
diabetes
albiglutide
GLP-1 agonist
Victoza
Byetta
Bydureon
Novo Nordisk
Bristol-Myers Squibb
AstraZeneca
Amarin's Anchor Will Hold As Vascepa's Sails Unfurl
Seeking Alpha
Fri, 06/21/13 - 08:51 am
Amarin
Vascepa
GSK
Arena Pharmaceuticals
Belviq
drug launches
AstraZeneca
AstraZeneca, Bristol diabetes drug disappoints in key test
Reuters
Wed, 06/19/13 - 10:28 am
Bristol-Myers Squibb
AstraZeneca
diabetes
Onglyza
AstraZeneca signs obesity and diabetes pact with NGM
Pharma Times, UK
Mon, 06/17/13 - 09:41 am
NGM Biopharmaceuticals
AstraZeneca
obesity
diabetes
Strong Product Pipelines Have Pharmaceutical Companies Poised for Growth
Motley Fool
Sat, 06/15/13 - 01:07 pm
Puma Biotechnology
Pfizer
AstraZeneca

Pages